Test Match: Two Anti-Itch Drugs Face OffMay 1, 2025Reducing pruritis is critical to enhancing quality of life for both patients and their people, hence the ongoing search for effective treatments. Ilunocitinib, a recently FDA-approved Janus kinase inhibitor, gave a powerful performance in a head-to-head match-up with Apoquel®.
SPONSORED CONTENTWhere unique needs meet innovative scienceFind precise, innovative solutions for your patients' unique needs + Learn More
